Literature DB >> 31313426

Comparison and evaluation of the efficacy of compressed SENSE (CS) and gradient- and spin-echo (GRASE) in breath-hold (BH) magnetic resonance cholangiopancreatography (MRCP).

Ming He1, Jin Xu1, Zhaoyong Sun1, Shitian Wang1, Liang Zhu1, Xiaoqi Wang2, Jiazheng Wang2, Feng Feng1, Huadan Xue1, Zhengyu Jin1.   

Abstract

CONTRACT GRANT SPONSOR: Chinese Academy of Medical Sciences (CAMS) Initiative for Innovative Medicine; Contract grant number: 2017-I2M-1-001; Contract grant sponsor: Outstanding Youth Fund of Peking Union Medical College Hospital; Contract grant number: JQ201704; Contract grant sponsor: National Natural Science Foundation of China; Contract grant number: 81871512; Contract grant sponsor: National Public Welfare Basic Scientific Research Program of Chinese Academy of Medical Sciences; Contract grant numbers: 2018PT32003 and 2017PT32004.
BACKGROUND: Both compressed-sensing (CS) and gradient- and spin-echo (GRASE) sequences can achieve 3D magnetic resonance cholangiopancreatography (MRCP) with a single breath-hold (BH). This work hypothesized that compared with conventional navigator-triggered (NT)-MRCP, the two BH-MRCP protocols, GRASE and CS, may provide better imaging quality, especially for patients with irregular breathing.
PURPOSE: To evaluate and compare the image quality and diagnostic performance of three MRCP protocols. STUDY TYPE: Prospective.
SUBJECTS: Seventy-four patients suspected to have duct-related pathologies were enrolled. FIELD STRENGTH: 3.0T. SEQUENCES: NT-MRCP, BH-CS-MRCP, and BH-GRASE-MRCP. ASSESSMENT: Breath regularity was evaluated subjectively according to the respiratory waves. The acquisition time was compared. The pancreaticobiliary system was divided into 12 segments and evaluated on a 5-point scale. The diagnostic performance of the three MRCPs was evaluated and compared. STATISTICAL TESTS: The Friedman test with a post-hoc test, receiver operating characteristic (ROC) curve analysis, McNemar test, and Kendall's W test were used.
RESULTS: The BH-MRCP decreased the scan time significantly (P < 0.05). The overall imaging scores of GRASE-MRCP and CS-MRCP were significantly higher than that of NT-MRCP for patients with irregular breathing (4.283 and 4.283 vs. 3.000, both P < 0.05). Compared with NT-MRCP, the diagnostic performance of BH-CS and BH-GRASE MRCP was significantly improved for patients with irregular breathing (AUC = 0.860 and 0.863 vs. 0.572, both P < 0.001). DATA
CONCLUSION: Compared with conventional NT-MRCP, the overall imaging quality and diagnostic performance of BH-CS and BH-GRASE MRCP were not significantly different for patients with regular breathing and significantly superior for patients with irregular breathing. LEVEL OF EVIDENCE: 2 Technical Efficacy: Stage 2 J. Magn. Reson. Imaging 2020;51:824-832.
© 2019 International Society for Magnetic Resonance in Medicine.

Entities:  

Keywords:  biliary tract; breath holding; magnetic resonance cholangiopancreatography; three-dimensional imaging

Mesh:

Year:  2019        PMID: 31313426     DOI: 10.1002/jmri.26863

Source DB:  PubMed          Journal:  J Magn Reson Imaging        ISSN: 1053-1807            Impact factor:   4.813


  3 in total

1.  Gradient- and spin-echo (GRASE) MR imaging: a long-existing technology that may find wide applications in modern era.

Authors:  Mei-Lan Chu; Cheng-Ping Chien; Wen-Chau Wu; Hsiao-Wen Chung
Journal:  Quant Imaging Med Surg       Date:  2019-09

2.  Three-dimensional static-fluid MR urography with gradient- and spin-echo (GRASE) at 3.0T: comparison of image quality and diagnostic performance with respiratory-triggered fast spin-echo (FSE).

Authors:  Wei Wang; Junzhe Yang; Jing Liu; Wei Li; Kai Zhao; Ke Xue; Yongming Dai; Jianxing Qiu
Journal:  Abdom Radiol (NY)       Date:  2022-03-02

3.  Compressed SENSE in Pediatric Brain Tumor MR Imaging : Assessment of Image Quality, Examination Time and Energy Release.

Authors:  Rieke L Meister; Michael Groth; Julian H W Jürgens; Shuo Zhang; Jan H Buhk; Jochen Herrmann
Journal:  Clin Neuroradiol       Date:  2022-01-07       Impact factor: 3.156

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.